Skip to main content

Prototype Prescribing Outlier Dashboard for Danetre Medical Practice

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Danetre Medical Practice is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Cyclizine lactate 219 Drugs used in nausea and vertigo 1,563 0.14 0.01 0.02 7.55
Co-phenotrope (Diphenox hydrochloride/atropine sulfate) 7 Antimotility drugs 202 0.03 0.00 0.00 7.47
Levothyroxine sodium and liothyronine 13 Thyroid hormones 5,613 0.00 0.00 0.00 6.15
Nefopam hydrochloride 523 Non-opioid analgesics and compound preparations 6,095 0.09 0.01 0.02 4.33
Diclofenac sodium 312 Non-steroidal anti-inflammatory drugs 1,784 0.17 0.04 0.03 4.14
Methyl salicylate/levomenthol 1 Rubefacients, topical NSAIDS, capsaicin and poultice 676 0.00 0.00 0.00 3.76
Triptorelin acetate 26 Prostate cancer and gonadorelin analogues 110 0.24 0.02 0.06 3.65
Empagliflozin/metformin 172 Other antidiabetic drugs 2,362 0.07 0.01 0.02 3.48
Ondansetron hydrochloride 254 Drugs used in nausea and vertigo 1,563 0.16 0.05 0.04 3.27
Sodium picosulfate 125 Stimulant laxatives 884 0.14 0.03 0.03 3.26

Prescribing where Danetre Medical Practice is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Procyclidine hydrochloride 11 Antimuscarinic drugs used in parkinsonism 52 0.21 0.85 0.21 -3.07
Loperamide hydrochloride 195 Antimotility drugs 202 0.97 1.00 0.01 -3.03
Mercaptopurine 0 Antimetabolites 13 0.00 0.80 0.35 -2.32
    Salicylic acid 0 Preparations for warts and calluses 13 0.00 0.67 0.31 -2.17
      Other multivitamin preparations 19 Multivitamin preparations 49 0.39 0.82 0.21 -2.10
      Methylprednisolone acetate 0 Local corticosteroid injections 217 0.00 0.74 0.39 -1.89
        Insulin glargine 89 Intermediate and long-acting insulins 895 0.10 0.33 0.13 -1.76
        Ganciclovir 0 Antivirals 8 0.00 0.63 0.43 -1.46
          Umeclidinium bromide/vilanterol 3 Compound bronchodilator preparations 42 0.07 0.50 0.30 -1.44
          Hydrocortisone 40 Copound haemorrhoidal preparations with corticosteroid 181 0.22 0.57 0.24 -1.43